These patients are susceptible to the complex scenario of CKD‐MBD, a disorder that following the development of hyperphosphatemia involves a progressive derangement of the FGF‐23–1,25(OH)2D–PTH axis, which is associated with an increased rate of bone fractures.58, 59, 60, 61. The gene discussed is FGF23; the disease is chronic kidney disease.